JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
Garrett Motion
GTX
$4.87B
| $1.31M | ﹤0.01% |
84,673
+18,834
| +29% | +$320K |
2018 Q4
2 quarters
|
|
3527
The RMR Group
RMR
$301M
| $1.31M | ﹤0.01% |
29,914
+1,276
| +4% | +$68.7K |
2015 Q4
14 quarters
|
|
3528
Piper Sandler
PIPR
$4.64B
| $1.31M | ﹤0.01% |
71,488
-88,428
| -55% | -$1.67M |
2013 Q2
24 quarters
|
|
3529
Exponent
EXPO
$3.29B
| $1.31M | ﹤0.01% |
22,405
+1,957
| +10% | +$111K |
2013 Q2
24 quarters
|
|
|
RFP
3530
DELISTED
Resolute Forest Products Inc.
RFP
| $1.3M | ﹤0.01% |
199,844
+193,660
| +3,132% | +$1.36M |
2013 Q2
24 quarters
|
|
3531
CALL
T. Rowe Price
TROW
$22.1B
| $1.3M | ﹤0.01% |
12,000
-8,000
| -40% | -$842K |
2018 Q3
3 quarters
|
|
|
3532
PUT
T. Rowe Price
TROW
$22.1B
| $1.3M | ﹤0.01% |
12,000
-8,000
| -40% | -$842K |
2018 Q3
3 quarters
|
|
3533
Towne Bank
TOWN
$3.27B
| $1.3M | ﹤0.01% |
47,787
+425
| +0.9% | +$11.2K |
2015 Q4
14 quarters
|
|
|
OXFD
3534
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.3M | ﹤0.01% |
94,354
+3,157
| +3% | +$48.3K |
2017 Q4
6 quarters
|
|
3535
Ocular Therapeutix
OCUL
$1.61B
| $1.29M | ﹤0.01% |
292,947
+275,307
| +1,561% | +$1.02M |
2017 Q1
9 quarters
|
|
3536
PUT
CF Industries
CF
$17.6B
| $1.29M | ﹤0.01% |
+27,400
| New | +$1.19M |
2019 Q2
0 quarters
|
|
3537
Park Aerospace
PKE
$654M
| $1.29M | ﹤0.01% |
77,327
+34,960
| +83% | +$561K |
2014 Q4
18 quarters
|
|
3538
Liberty Global Class A
LBTYA
$3.12B
| $1.28M | ﹤0.01% |
47,988
-407
| -0.8% | -$10.7K |
2013 Q2
24 quarters
|
|
|
UCFC
3539
DELISTED
United Community Financial Corp
UCFC
| $1.28M | ﹤0.01% |
135,573
-2,462
| -2% | -$23K |
2014 Q4
18 quarters
|
|
3540
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.59B
| $1.28M | ﹤0.01% |
42,090
+2,463
| +6% | +$74.4K |
2013 Q2
24 quarters
|
|
|
CTLP
3541
DELISTED
Cantaloupe
CTLP
| $1.27M | ﹤0.01% |
177,558
+152,094
| +597% | +$942K |
2017 Q4
6 quarters
|
|
3542
CALL
MPLX
MPLX
$58.6B
| $1.27M | ﹤0.01% |
+40,000
| New | +$1.27M |
2019 Q2
0 quarters
|
|
|
3543
PUT
MPLX
MPLX
$58.6B
| $1.27M | ﹤0.01% |
+40,000
| New | +$1.27M |
2019 Q2
0 quarters
|
|
3544
CALL
Zoom
ZM
$27.5B
| $1.27M | ﹤0.01% |
+14,100
| New | +$1.16M |
2019 Q2
0 quarters
|
|
|
FPI
3545
Farmland Partners
FPI
$469M
| $1.27M | ﹤0.01% |
180,724
-34,162
| -16% | -$221K |
2016 Q1
13 quarters
|
|
3546
PUT
Axsome Therapeutics
AXSM
$9.13B
| $1.27M | ﹤0.01% |
+50,000
| New | +$1M |
2019 Q2
0 quarters
|
|
3547
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$674M
| $1.26M | ﹤0.01% |
24,639
+66
| +0.3% | +$3.34K |
2016 Q4
10 quarters
|
|
|
CSR
3548
Centerspace
CSR
$931M
| $1.26M | ﹤0.01% |
21,890
+4,861
| +29% | +$289K |
2016 Q4
10 quarters
|
|
3549
CALL
Halozyme
HALO
$12.5B
| $1.26M | ﹤0.01% |
75,000
+45,000
| +150% | +$726K |
2018 Q4
2 quarters
|
|
3550
Oxford Industries
OXM
$382M
| $1.26M | ﹤0.01% |
17,086
-11,576
| -40% | -$886K |
2015 Q4
14 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.